01440 782 100 (Monday - Friday 8.30am - 5pm)
BOOK A TOUR
01440 782 100
BOOK TOUR

MultiplAI Heath – Graduated in July 2023

MultiplAI Health is redefining the future of healthcare with their ground-breaking RNA-based, AI-driven screening technology. After graduating from The EpiCentre in July 2023, MultiplAI Health has continued to accelerate innovation in early disease detection, developing a simple blood test that transforms how cardiovascular and complex diseases are diagnosed. Their mission is to make routine and frequent screening accessible to everyone, empowering timely intervention and improved outcomes for patients worldwide.

In February 2024, MultiplAI Health announced that their disease screening results already surpass clinical standards, setting a new benchmark for accuracy and reliability in the field.

May 2025 marked another milestone, as MultiplAI Health celebrated the publication of their first scientific paper supporting CardioMet-RNAseq™ in the European Heart Journal – Digital Health. This recognition underscores the impact of their technology and the dedication of their team to advancing medical science.

To find out more about Office Space | The EpiCentre | Haverhill, Cambridge (epicentrehaverhill.co.uk)

To find out more about Lab Space | The EpiCentre | Haverhill, Cambridge (epicentrehaverhill.co.uk)

To find out more about  Our Members | The EpiCentre | Haverhill, Cambridge (epicentrehaverhill.co.uk)

To find out more about Business Support | EpiCentre | Cambridge, Haverhill (epicentrehaverhill.co.uk)

Amphista Therapeutics – Graduated in March 2022

14 November 2025

Since graduating from The EpiCentre in March 2022, Amphista has established itself at Granta Park, Cambridge, a world-leading hub for biopharmaceutical innovation. Amphista’s mission is to unlock the full potential of Targeted Protein Degradation (TPD) by developing a new generation of transformational medicines using their proprietary Targeted Glue® technology.

READ MORE »

MultiplAI Heath – Graduated in July 2023

14 November 2025

MultiplAI Health is redefining the future of healthcare with their ground-breaking RNA-based, AI-driven screening technology. After graduating from The EpiCentre in July 2023, MultiplAI Health has continued to accelerate innovation in early disease detection, developing a simple blood test that transforms how cardiovascular and complex diseases are diagnosed.

READ MORE »

K9 Digital – Graduated in July 2025

14 November 2025

K9 Digital stands out as a creative powerhouse within The EpiCentre’s vibrant community. Founded by industry veterans with a passion for character creation, K9 Digital specialises in 3D character, creature, and animal art for games, VR, TV, and film.

READ MORE »

PES Technologies – Graduated in May 2025

14 November 2025

PES Technologies embodies the pioneering spirit at the heart of The EpiCentre community. After graduating from the centre in May 2025, PES Technologies has continued to make waves in the agri-tech sector, driven by their mission to revolutionise soil health measurement.

READ MORE »

Ready to find your new workspace?

Be at centre of an inspiring and ambitious science and technology community. Be at The EpiCentre.

Get in touch >>

Book a Tour

Join an inspiring community of innovators and entrepreneurs.

  • Book a tour of The EpiCentre
  • Get more information on workspace sizes, pricing & availability
  • Have your questions answered
  • Secure your choice of office, lab, coworking or meeting space

01440 782 100
(Monday – Friday 8.30am – 5pm)

info@epicentrehaverhill.co.uk

This field is for validation purposes and should be left unchanged.
Name

Subscribe for Updates

Stay in touch with what’s happening at The EpiCentre. Pop in your details below and confirm you’re happy for us to send you emails, and we’ll keep you up to date with all that’s happening at The EpiCentre.

Name

Disclaimer: The EpiCentre uses the information you provide on this form to get in touch with you and provide updates and for marketing purposes. You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us. We treat all personal information with respect. By subscribing, you agree that we may process your information in accordance with these terms.

Get in Touch

Join an inspiring and ambitious community. 

  • Get more information on workspace sizes, pricing & availability
  • Have your questions answered
  • Secure your choice of office, lab, coworking or meeting space

01440 782 100
(Monday – Friday 8.30am – 5pm)

info@epicentrehaverhill.co.uk

This field is for validation purposes and should be left unchanged.
I'm interested in...
Name(Required)

Download our lab space brochure to find out more about our range of workspace packages and facilities

This field is for validation purposes and should be left unchanged.

Download our lab space brochure to find out more about our range of workspace packages and facilities

This field is for validation purposes and should be left unchanged.

Ready to explore our Lab Space options?

Space to experiment, space to research

  • Get more information on pricing & availability
  • Book a tour of The EpiCentre lab space
  • Have your questions answered
  • Reserve your lab space

01440 782 100
(Monday – Friday 8.30am – 5pm)
info@epicentrehaverhill.co.uk

This field is for validation purposes and should be left unchanged.
Name

Ready to sign up for Lab space?

Space to experiment, space to research

  • Get more information on pricing & availability
  • Arrange a viewing of The EpiCentre lab space
  • Have your questions answered
  • Reserve your lab space

01440 782 100
(Monday – Friday 8.30am – 5pm)
info@epicentrehaverhill.co.uk

This field is for validation purposes and should be left unchanged.
Name

Covid-19 Statement

Update – 11 August 2022

Our Innovation Centres remain operational and accessible, and provide a safe environment for our staff and customers. We continue to assess the risk of COVID-19 alongside the latest guidance from government. In the meantime our Innovation Centre remains COVID-19 Secure and fully open for business. Our detailed risk assessment can be found here.